ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 271 filers reported holding ACCELERON PHARMA INC in Q2 2021. The put-call ratio across all filers is 1.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $14,206,000 | -49.9% | 82,549 | -63.5% | 0.02% | -50.0% |
Q2 2021 | $28,361,000 | -16.2% | 226,005 | -9.5% | 0.04% | -21.4% |
Q1 2021 | $33,863,000 | -7.0% | 249,705 | -12.2% | 0.06% | -13.8% |
Q4 2020 | $36,395,000 | +13.5% | 284,475 | -0.1% | 0.06% | +3.2% |
Q3 2020 | $32,059,000 | +37.4% | 284,893 | +16.3% | 0.06% | +26.0% |
Q2 2020 | $23,331,000 | +59.5% | 244,893 | +50.5% | 0.05% | +31.6% |
Q1 2020 | $14,626,000 | +197.9% | 162,747 | +75.8% | 0.04% | +280.0% |
Q4 2019 | $4,909,000 | +77.2% | 92,575 | +32.1% | 0.01% | +66.7% |
Q3 2019 | $2,770,000 | -3.6% | 70,104 | +0.2% | 0.01% | 0.0% |
Q2 2019 | $2,873,000 | -11.8% | 69,947 | 0.0% | 0.01% | -25.0% |
Q1 2019 | $3,257,000 | +7.0% | 69,947 | +0.1% | 0.01% | 0.0% |
Q4 2018 | $3,044,000 | -18.2% | 69,880 | +7.5% | 0.01% | 0.0% |
Q3 2018 | $3,719,000 | +47.9% | 64,984 | +25.4% | 0.01% | +166.7% |
Q2 2018 | $2,514,000 | +124.9% | 51,808 | +81.2% | 0.00% | 0.0% |
Q1 2018 | $1,118,000 | -53.6% | 28,588 | -49.7% | 0.00% | 0.0% |
Q4 2017 | $2,410,000 | +51.6% | 56,792 | +33.2% | 0.00% | -25.0% |
Q3 2017 | $1,590,000 | +74.3% | 42,628 | +42.0% | 0.00% | +100.0% |
Q2 2017 | $912,000 | -74.8% | 30,014 | -78.1% | 0.00% | -77.8% |
Q1 2017 | $3,621,000 | +2.6% | 136,800 | -1.1% | 0.01% | 0.0% |
Q4 2016 | $3,530,000 | -29.9% | 138,305 | -0.5% | 0.01% | -25.0% |
Q3 2016 | $5,033,000 | +18.5% | 139,053 | +11.2% | 0.01% | +20.0% |
Q2 2016 | $4,248,000 | +28.8% | 125,000 | 0.0% | 0.01% | +25.0% |
Q1 2016 | $3,299,000 | -45.9% | 125,000 | 0.0% | 0.01% | -42.9% |
Q4 2015 | $6,095,000 | +95.1% | 125,000 | -0.4% | 0.01% | +100.0% |
Q3 2015 | $3,124,000 | -21.3% | 125,472 | 0.0% | 0.01% | -12.5% |
Q2 2015 | $3,970,000 | – | 125,472 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |